dc.contributor.author | Lim, JSJ | |
dc.contributor.author | Collins, D | |
dc.contributor.author | Yap, TA | |
dc.date.accessioned | 2017-03-01T17:09:24Z | |
dc.date.issued | 2016-10-01 | |
dc.identifier.citation | Journal of thoracic disease, 2016, 8 (10), pp. E1249 - E1253 | |
dc.identifier.issn | 2072-1439 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/460 | |
dc.identifier.eissn | 2077-6624 | |
dc.identifier.doi | 10.21037/jtd.2016.10.46 | |
dc.format | Print | |
dc.format.extent | E1249 - E1253 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | AME PUBLISHING COMPANY | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | Emerging strategies for the treatment of advanced small cell lung cancer. | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.21037/jtd.2016.10.46 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-10 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Journal of thoracic disease | |
pubs.issue | 10 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicine Drug Development Unit (de Bono) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine Drug Development Unit (de Bono) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicine Drug Development Unit (de Bono) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine Drug Development Unit (de Bono) | |
pubs.publication-status | Published | |
pubs.volume | 8 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Medicine Drug Development Unit (de Bono) | |
dc.contributor.icrauthor | Collins, David | |